Research Article
The Changing Epidemiology of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy
Table 1
Patient demographics of 215 subjects by colonization status.
| | Colonized | | | Yes () | No () | -value |
| Age, mean (SD) | 42.7 (8.9) | 42.3 (8.5) | 0.7791 | Male, (%) | 157 (89.7) | 34 (85) | 0.3932 | White, (%) | 54 (30.9) | 7 (17.5) | 0.1343 | Non-Hispanic, (%) | 82 (46.9) | 11 (27.5) | 0.0262 | Years since diagnosis of HIV/AIDS, mean (SD) | 8.4 (6.9) | 6.4 (6.5) | 0.0864 | Diabetic, (%) | 15 (8.5) | 2 (5) | 0.7453 | History of Smoking, (%) | 127 (72.1) | 24 (60) | 0.1172 | Uses dentures, (%) | 42 (23.8) | 3 (7.5) | 0.0183 | Thrush present, (%) | 59 (33.5) | 0 (0) | <0.0013 | History of esophageal Candida, (%) | 8 (4.5) | 3 (7.5) | 0.4333 | Decreased susceptibility to fluconazole, (%) | 16 (9.1) | 0 (0) | 0.0472 | On ART therapy, (%) | 117 (66.4) | 31 (79.5) | 0.1452 | History of antifungal use, (%) | 59 (33.5) | 20 (50) | 0.0542 | CD4 count, mean (SD) | 102.8 (80.3) | 84.9 (67.8) | 0.2834 | Viral load, mean (SD) | 607142.5 (3442957.1) | 103189.7 (161265.9) | 0.5884 |
|
|
1 test.
2Pearson's test.
3Fisher's exact test.
4Kruskal-Wallis test.
|